EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Polymer‐Based mRNA Delivery Strategies for Advanced Therapies

Wenqian Yang iD, Lucas Mixich, Eger Boonstra, Horacio Cabral iD

Advanced Healthcare Materials · 2023-06 · 12 (15)

DOI: 10.1002/adhm.202202688 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.02.2023. Verfasst von Wenqian Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan. Hauptthemen laut MEDLINE: Nanoparticles, Cancer Vaccines. Die Arbeit wurde bisher 174-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA)‐based therapies offer great promise for the treatment of a variety of diseases. In 2020, two FDA approvals of mRNA‐based vaccines have elevated mRNA vaccines to global recognition. However, the therapeutic capabilities of mRNA extend far beyond vaccines against infectious diseases. They hold potential for cancer vaccines, protein replacement therapies, gene editing therapies, and immunotherapies. For realizing such advanced therapies, it is crucial to develop effective carrier systems. Recent advances in materials science have led to the development of promising nonviral mRNA delivery systems. In comparison to other carriers like lipid nanoparticles, polymer‐based delivery systems often receive less attention, despite their unique ability to carefully tune their chemical features to promote mRNA protection, their favorable pharmacokinetics, and their potential for targeting delivery. In this review, the central features of polymer‐based systems for mRNA delivery highlighting the molecular design criteria, stability, and biodistribution are discussed. Finally, the role of targeting ligands for the future of RNA therapies is analyzed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesCancer VaccinesPolymersRNA, MessengerTissue DistributionGenetic Therapy

Stichwörter der Autor:innen

ligand-mediated targetingmessenger RNApolymer-based delivery systems

Substanzen

PolymersRNA, MessengerCancer Vaccines

Autor:innen und Institutionen

  • Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan.

ORCID-Profile: Wenqian Yang, Horacio Cabral

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Yang, W., Mixich, L., Boonstra, E., & Cabral, H. (2023). Polymer‐Based mRNA Delivery Strategies for Advanced Therapies. Advanced Healthcare Materials, 12(15). https://doi.org/10.1002/adhm.202202688

Vancouver

Yang W, Mixich L, Boonstra E, Cabral H. Polymer‐Based mRNA Delivery Strategies for Advanced Therapies. Advanced Healthcare Materials. 2023;12(15). doi:10.1002/adhm.202202688

BibTeX
@article{Yang2023,
  author = {Yang, Wenqian and Mixich, Lucas and Boonstra, Eger and Cabral, Horacio},
  title = {Polymer‐Based mRNA Delivery Strategies for Advanced Therapies},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {15},
  doi = {10.1002/adhm.202202688}
}
Kostenlos starten →